TALLINI, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 12.547
NA - Nord America 11.317
EU - Europa 9.252
AF - Africa 1.052
SA - Sud America 793
OC - Oceania 277
Continente sconosciuto - Info sul continente non disponibili 17
Totale 35.255
Nazione #
US - Stati Uniti d'America 11.178
SG - Singapore 3.204
CN - Cina 2.921
VN - Vietnam 2.787
IT - Italia 2.358
GB - Regno Unito 2.268
DE - Germania 1.129
HK - Hong Kong 891
SE - Svezia 738
IN - India 694
BR - Brasile 608
RU - Federazione Russa 478
IQ - Iraq 438
FR - Francia 365
KR - Corea 355
UA - Ucraina 353
NL - Olanda 340
IE - Irlanda 296
AU - Australia 263
PK - Pakistan 238
ZA - Sudafrica 183
JP - Giappone 172
CI - Costa d'Avorio 171
EG - Egitto 152
CH - Svizzera 148
EE - Estonia 141
FI - Finlandia 131
SC - Seychelles 130
TR - Turchia 126
LY - Libia 122
JO - Giordania 93
ID - Indonesia 88
SA - Arabia Saudita 87
IR - Iran 86
CA - Canada 83
BG - Bulgaria 80
AR - Argentina 78
NG - Nigeria 75
TG - Togo 74
ES - Italia 70
BD - Bangladesh 64
DZ - Algeria 61
AT - Austria 59
PL - Polonia 49
GR - Grecia 46
MX - Messico 40
MY - Malesia 37
EC - Ecuador 31
PH - Filippine 30
PS - Palestinian Territory 30
BE - Belgio 29
AE - Emirati Arabi Uniti 24
PT - Portogallo 21
CZ - Repubblica Ceca 19
RS - Serbia 19
CO - Colombia 18
OM - Oman 18
SY - Repubblica araba siriana 18
LT - Lituania 17
MA - Marocco 17
PY - Paraguay 17
CL - Cile 16
NP - Nepal 16
RO - Romania 16
YE - Yemen 15
AF - Afghanistan, Repubblica islamica di 14
UZ - Uzbekistan 14
XK - ???statistics.table.value.countryCode.XK??? 14
LB - Libano 13
MK - Macedonia 13
TW - Taiwan 13
KZ - Kazakistan 11
PE - Perù 10
SI - Slovenia 10
SK - Slovacchia (Repubblica Slovacca) 10
DK - Danimarca 9
HR - Croazia 9
IL - Israele 8
LV - Lettonia 8
VE - Venezuela 8
KE - Kenya 7
TN - Tunisia 7
ZW - Zimbabwe 7
AL - Albania 6
FJ - Figi 6
NO - Norvegia 6
SN - Senegal 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
GE - Georgia 5
IS - Islanda 5
KW - Kuwait 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
AZ - Azerbaigian 4
CY - Cipro 4
MU - Mauritius 4
NA - Namibia 4
SO - Somalia 4
TH - Thailandia 4
Totale 35.187
Città #
Singapore 2.031
Southend 1.965
Fairfield 1.288
Ashburn 1.275
Hong Kong 859
Hefei 825
Ho Chi Minh City 739
Chandler 642
Bologna 634
Hanoi 627
Houston 591
Woodbridge 575
Wilmington 526
Seattle 523
Cambridge 458
Princeton 436
Santa Clara 389
Seoul 345
Ann Arbor 338
Boardman 308
Beijing 296
Dublin 292
Dallas 281
Jacksonville 205
Los Angeles 188
Milan 174
Abidjan 171
Westminster 167
Dong Ket 166
Nanjing 165
Baghdad 163
Padova 159
Berlin 151
Tokyo 146
Melbourne 143
Bern 123
Buffalo 106
New York 104
Saint Petersburg 101
Helsinki 95
Amman 93
Bengaluru 93
Da Nang 92
Jinan 91
Frankfurt am Main 85
Redmond 83
Turin 83
Redondo Beach 82
Sofia 75
Lomé 74
Shenyang 74
San Diego 73
Rome 71
Erbil 70
Haiphong 65
Tripoli 63
Lahore 62
Florence 60
Hebei 60
São Paulo 59
Changsha 56
Ha Long 56
Jeddah 56
Amsterdam 55
Jakarta 54
Munich 54
Hyderabad 53
Quận Bình Thạnh 52
Cairo 49
Hangzhou 47
Mülheim 47
Shanghai 47
Tianjin 46
Des Moines 45
Chicago 44
Istanbul 43
Medford 43
Vũng Tàu 43
Biên Hòa 42
London 42
Nuremberg 42
Groningen 41
Jiaxing 41
Thái Nguyên 41
Falls Church 40
Zhengzhou 40
Ninh Bình 39
Guangzhou 38
Nanchang 38
Warsaw 38
Redwood City 33
The Dalles 33
Chennai 32
Hải Dương 31
Islamabad 31
Lagos 31
Naples 31
Verona 30
Vienna 30
Bắc Ninh 29
Totale 21.961
Nome #
Thyroid Gland 2.601
Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation. 572
Robbins e Cotran: Le basi patologiche delle malattie. 437
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 406
The role of next-generation sequencing in the cytologic diagnosis of pancreatic lesions 354
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 318
Molecular biology of biliopancreatic lesions 315
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance 308
Correction to: Visani et al. mir-196b-5p and mir-200b-3p are differentially expressed in medulloblastomas of adults and children. diagnostics 2020, 10, 265 265
Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma 258
BRAF exon 15 mutations in papillary carcinoma and adjacent thyroid parenchyma: A search for the early molecular events associated with tumor development 256
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 235
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 221
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 220
T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer 212
BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma 211
Clival chordomas: considerations after 16 years of endoscopic endonasal surgery 204
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples 204
Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification 198
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer 194
Next-generation technologies in predictive molecular pathology of lung cancers 194
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 193
Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III 193
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors 193
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 190
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 186
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 185
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 180
Ectopic Thyroid Tissue in the Adrenal Gland: Report of a Case. 179
RET mutation and increased angiogenesis in medullary thyroid carcinomas 179
Three-dimensional reconstruction of vessel distribution in benign and malignant lesions of thyroid. 174
‘Incidental thyroid cancer’ is not synonymous with ‘overdiagnosis’ 172
BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer 172
Tumors of the thyroid and Parathyroid Glands 172
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 171
Cutaneous Melanoma with "Paradoxical" p16 Hyper-expression: Molecular and Immunohistochemical Analysis of an Exceedingly Rare Entity with a Focus on Regulator Molecules of the Cell Cycle 170
Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumours. 168
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) 165
Oncocytic carcinoma of the breast: frequency, morphology and follow-up 165
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology 163
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 161
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas 160
Molecular analysis driven video-assisted thoracic surgery resections in bilateral synchronous lung cancers: From the test tube to the operatory room 160
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria 160
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 159
BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. 155
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors 155
Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients 155
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients 154
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer 152
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas 150
Team work and cytopathology molecular diagnosis of solid pancreatic lesions 150
MiR-196B-5P and miR-200B-3P are differentially expressed in medulloblastomas of adults and children 150
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH 150
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 148
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer 148
Relevance of ARID1A Mutations in Endometrial Carcinomas 147
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status 146
Where Birt-Hogg-Dubé meets Cowden Syndrome: Mirrored genetic defects in two cases of syndromic oncocytic tumours 146
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literature 144
The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization 144
Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping 143
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4 141
Multifocal Fibrosing Thyroiditis: an Under-recognized Mimicker of Papillary Thyroid Carcinoma 140
Relationship among clinical, pathological and bio-molecular features in low-grade epilepsy-associated neuroepithelial tumors 140
Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer 140
Next Generation Sequencing Improves the Accuracy of KRAS Mutation Analysis in Endoscopic Ultrasound Fine Needle Aspiration Pancreatic Lesions 138
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas 138
Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity 137
Contribution of microRNA analysis to characterisation of pancreatic lesions: A review 137
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma 136
A rare case of intracranial extra-axial ependymoma 136
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 136
Analysis of MDM2 and TP53 genes in canine liposarcoma 135
BRAF T1796A transversion mutation in various thyroid neoplasms. J Clin Endocrinol Metab. 2004;89:1365-1368 135
What’s new in Thyroid tumor classification, the 2017 World Health Organization Classification of Tumours of Endocrine Organs 135
Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut 134
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma 134
Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women. 134
Assessment of RET/PTC oncogene activation in thyroid nodules utilizing laser microdissection followed by nested RT-PCR 134
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor 134
What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 world health organization classification of female genital tumors 133
Microsatellite instabilityDNA testing in routinely processed colorectal carcinomas: correlation with clinicopathologic and survival data in 340 consecutive cases 132
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy) 132
"Paradoxical" p16 overexpression in cutaneous melanoma: Molecular and immunohistochemical analysis of a rare phenomenon with a focus on cell cycle regulatory molecules 131
High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas. 131
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer 131
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal 131
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results 130
Search for HBV and HCV Genome in Cancer Cells of Pancreatic Tumors 130
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. 129
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center 128
Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Contro 128
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma 128
Morpho-molecular approach (NGS plus digital PCR) in diagnosis of malignant biliary strictures 127
Journal of Molecular Diagnostics 127
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 127
Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations 126
Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies 126
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants 126
Totale 19.937
Categoria #
all - tutte 100.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.589 0 0 0 0 0 181 87 159 297 158 132 575
2021/20223.533 247 121 204 259 392 220 109 266 183 228 759 545
2022/20233.783 382 440 194 437 227 256 108 250 664 181 335 309
2023/20242.324 136 207 86 121 145 244 170 251 197 327 268 172
2024/20257.269 382 1.020 633 553 763 408 543 267 240 513 553 1.394
2025/20269.783 2.796 1.832 1.690 1.365 1.390 710 0 0 0 0 0 0
Totale 35.964